WIC
CLDX icon

Water Island Capital’s Celldex Therapeutics CLDX Stock Holding History

Water Island Capital’s Portfolio CLDX Stock Details CLDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-1,000
Closed -$57K – 157
2016
Q1 		$57K Buy
+1,000
New +$113K ﹤0.01% 110

Other funds holding CLDX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
CWAM
Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BIM
Bogle Investment Management Newton Lower Falls, Massachusetts $63M AUM 51.97% 1-Year Est. Return

Water Island Capital's CLDX Position: Q2 2016 in Review

Water Island Capital sold out of Celldex Therapeutics (CLDX) in Q2 2016, closing a stake of 1,000 shares — an estimated $57K sold.

Water Island Capital first reported a position in CLDX in Q1 2016 and held it in 1 quarter. The position peaked at $57K in Q1 2016. 141 funds tracked by Wall St. Rank hold CLDX as of Q2 2016.

  • Water Island Capital reported no remaining Celldex Therapeutics position as of Q2 2016 after selling out during the quarter.
  • Water Island Capital sold 1,000 Celldex Therapeutics shares in Q2 2016, an estimated $57K.
  • Water Island Capital first reported a position in Celldex Therapeutics in Q1 2016 and held it in 1 quarter.
  • Water Island Capital's Celldex Therapeutics position peaked at $57K in Q1 2016.
  • 141 funds tracked by Wall St. Rank held Celldex Therapeutics as of Q2 2016.

Based on Water Island Capital's 13F filing for Q2 2016, filed 15 Aug 2016.